|
Therapeutic peptide targets RAS signal transduction pathways, and can be utilized for indications associated with these pathways
Abstract
USC researchers have discovered that the novel oral formulation of Nle3-A(1-7) has the unexpected result that shows significantly more potent therapeutic effects than corresponding compositions. This oral formulation...
|